BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20691415)

  • 1. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment.
    Bornstein E; Lenchner E; Donnenfeld A; Jodicke C; Keeler SM; Kapp S; Divon MY
    Am J Obstet Gynecol; 2010 Oct; 203(4):391.e1-5. PubMed ID: 20691415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of modes of ascertainment for mosaic vs complete trisomy 21.
    Bornstein E; Lenchner E; Donnenfeld A; Kapp S; Keeler SM; Divon MY
    Am J Obstet Gynecol; 2009 Apr; 200(4):440.e1-5. PubMed ID: 19318154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
    Goncé A; Borrell A; Fortuny A; Casals E; Martínez MA; Mercadé I; Cararach V; Vanrell JA
    Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative real-time PCR technique for rapid prenatal diagnosis of Down syndrome.
    Hu Y; Zheng M; Xu Z; Wang X; Cui H
    Prenat Diagn; 2004 Sep; 24(9):704-7. PubMed ID: 15386450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis.
    Donaghue C; Mann K; Docherty Z; Ogilvie CM
    Prenat Diagn; 2005 Jan; 25(1):65-72. PubMed ID: 15662691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
    Witters I; Fryns JP
    Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal diagnosis of common chromosomal aneuploidies on uncultured amniotic fluid cells by fluorescence in situ hybridization].
    Xiao HM; Tan YQ; Li LY; Lu GX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):608-10. PubMed ID: 15583993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours].
    Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E
    Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
    BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of partial monosomy 18p(18p11.2-->pter) and trisomy 21q(21q22.3-->qter) with alobar holoprosencephaly and premaxillary agenesis.
    Chen CP; Chern SR; Wang W; Lee CC; Chen WL; Chen LF; Chang TY; Tzen CY
    Prenat Diagn; 2001 May; 21(5):346-50. PubMed ID: 11360273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
    Calda P; Sípek A; Gregor V
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.